Form 8-K - Current report:
SEC Accession No. 0001062993-16-010415
Filing Date
2016-07-06
Accepted
2016-07-06 14:38:24
Documents
2
Period of Report
2016-07-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 5610
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 6679
  Complete submission text file 0001062993-16-010415.txt   13559
Mailing Address SUITE 950, 1130 WEST PENDER STREET VANCOUVER A1 V6E 4A4
Business Address SUITE 950, 1130 WEST PENDER STREET VANCOUVER A1 V6E 4A4 604-602-1675
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52138 | Film No.: 161753428
SIC: 1000 Metal Mining